Latest Equity Issuance News

Locate Technologies has agreed to settle its remaining Locate2u revenue royalty by issuing 10 million shares to PURE Asset Management at a significant premium to market price, simplifying funding and improving cash flow.

Truscreen Group has issued nearly 150 million new shares at NZ$0.013 each, expanding its share base by 17.4% following a renounceable rights issue. The fully paid shares rank equally with existing stock, lifting total ordinary shares to just over one billion.

Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.

Whitefield Industrials updates its dividend details for the half-year ending March 2026, confirming a fully franked dividend of 10.5 cents per share and setting reinvestment plan prices at AUD 4.57 without discounts.

Xingye Gold (Hong Kong) Mining Company Limited has opened an off-market takeover bid for Far East Gold Limited at $0.13 per share, offering a significant premium amid stalled projects and funding concerns.

Decidr AI Industries has successfully completed a $15 million placement to fund key product development and expansion initiatives, reinforcing its lead in the agentic AI sector.

Beetaloo Energy has secured full underwriting for its $5 million Share Purchase Plan, with shareholder approval for the share issuance and any shortfall shares to be sought at the upcoming AGM on 29 May 2026.

SSH Group Ltd is set to acquire Elphinstone Mechanical Services, boosting its revenue scale and geographic reach into Queensland and New South Wales with an immediately accretive deal.

Sunstone Metals reported robust growth at its Bramaderos gold-copper project with a 3.6Moz AuEq resource and substantial exploration targets. Drilling at Copete and Porotillo prospects confirmed mineralisation continuity, underpinning potential resource upgrades.

Algorae Pharmaceuticals strengthened its balance sheet with $5.47 million cash reserves and broadened its commercial footprint through new licensing deals and AI-driven drug validation.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

NH3 Clean Energy has marked strong progress in its WAH2 clean ammonia project by appointing Linde Engineering for FEED and securing a 15-year water supply agreement, setting the stage for a final investment decision by year-end.